Rituximab in autoimmune pancytopenia: A case report and review of literature

Annals of Hematology

Volumn 86, Issue 12, 2007, Pages 913-916

  Reale, Lisa D ^a   Besa, Emmanuel C ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB;

ADULT; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; CASE REPORT; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; LETTER; NEUTROPENIA; PANCYTOPENIA; RECURRENT DISEASE;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; AZATHIOPRINE; ERYTHROCYTE TRANSFUSION; FEMALE; FILGRASTIM; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEUTROPENIA; PANCYTOPENIA; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE;

EID: 40949147540     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-007-0316-4     Document Type: Letter

References (15)

1. Braendstrup P, Bjerrum O, Nielsen O, Jensen B, Clausen N, Hansen P, Andersen I, Schmidt K, Andersen T, Peterslund N, Birgens H, Plesner T, Pedersen B, Hasselbalch H (2005) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 78:275-280
2. CooperN, Stasi R, Cunningham-Rundles S, FeuersteinM, Leonard J, Amadori S, Bussel J (2004) The efficacy and safety of B-cell depletionwith anti-CD20monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125:232-239
3. Dungarwalla M, Marsh JC, Tooze JA, Lucas G, Ouwehand W, Pettengell R, Dearden CE, Gordon Smith EC, Elebute MO (2007) Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia. Ann Hematol 86:191-197
4. Faurschou M, Hasselbalch H, Nielsen O (2001) Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia. Eur J Haematol 66:408-411
5. Fianchi L, Rossi E, Murri R, De Stefano V, Pagano L, Leone G (2007) Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura. Ann Hematol 86:225-226
6. Giagounidis A, Anhuf J, Schneider P, Germing U, Sohngen D, Quabeck K, Aul C (2002) Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur J Haematol 69:95-100
7. Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, Rai K (2002) Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia 6:2092-2095
8. Narat S, Gandla J, Hoffbrand A, Hughes R, Mehta A (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica 90(9):1273-1274
9. Saleh M, Gutheil J, Moore M, Bunch P, Butler J, Kunkel L, Grillo-Lopez A, LoBuglio A (2000) A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin Oncol 27(6 Suppl 12): 99-103
10. Santos ES, Arosemena LR, Raez LE, O'Brien C, Regev A (2006) Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature. Liver Int 26:625-629
11. Shanafelt T, Madueme H, Wolf R, Tefferi A (2003) Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Evans syndrome. Mayo Clin Proc 78:1340-1346
12. Stasi R, Pagano A, Stipa E, Amadori S (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98(4):952-957
13. Stasi R, Stipa E, Forte V, Meo P, Amadori S (2002) Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood 99:3872-3873
14. Trape G, Fianchi L, Lai M, Laurenti L, Piscitelli R, Leone G, Pagano L (2003) Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. Haematologica 88:223-225
15. Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A, Masolini P, Tomadini V, Tani M, Molinari A, Baccarani M, Fanin R (2003) B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica 88:538-546